Heterogeneous expression of FLT3 on the mRNA level and on the cell surface in B-ALL patients has been reported by other investigators [34,35,36], and a trend for a correlation of low FLT3 expression and relapse was observed in an Indian cohort of ALL patients, without reaching statistical significance [34]. The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.